Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Pfeuffer

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Brain Communications|August 18, 2021
Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activationLeoni Rolfes, Andreas Schulte-Mecklenbeck, Stefanie Schreiber, et al.
Neurology|November 9, 2018
Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cellsTobias Ruck, Steffen Pfeuffer, Andreas Schulte-Mecklenbeck, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2026
Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activityFranz Felix Konen, Franziska Axhausen, Stephanie Wolff, et al.
Journal of Neuroinflammation|September 7, 2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapsesSteffen Pfeuffer, Leoni Rolfes, Timo Wirth, et al.
Frontiers in Neurology|October 17, 2017
An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet FunctionIlka Kleffner, Susann Eichler, Tobias Ruck, et al.
Annals of Clinical and Translational Neurology|November 5, 2019
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosisChristian W Keller, Tobias Ruck, Donal McHugh, et al.
Multiple Sclerosis and Related Disorders|June 11, 2022
Immunological consequences of cladribine treatment in multiple sclerosis: A real-world studyLeoni Rolfes, Steffen Pfeuffer, Niklas Huntemann, et al.
Cells|May 13, 2023
Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving CladribineLeoni Rolfes, Steffen Pfeuffer, Jelena Skuljec, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 24, 2021
Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatmentKristina Schönfelder, Helene Schuh, Frederick Pfister, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2023
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With OcrelizumabSteffen Pfeuffer, Leoni Rolfes, Jens Ingwersen, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Brain Communications|August 18, 2021
Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activationLeoni Rolfes, Andreas Schulte-Mecklenbeck, Stefanie Schreiber, et al.
Neurology|November 9, 2018
Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cellsTobias Ruck, Steffen Pfeuffer, Andreas Schulte-Mecklenbeck, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2026
Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activityFranz Felix Konen, Franziska Axhausen, Stephanie Wolff, et al.
Journal of Neuroinflammation|September 7, 2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapsesSteffen Pfeuffer, Leoni Rolfes, Timo Wirth, et al.
Frontiers in Neurology|October 17, 2017
An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet FunctionIlka Kleffner, Susann Eichler, Tobias Ruck, et al.
Annals of Clinical and Translational Neurology|November 5, 2019
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosisChristian W Keller, Tobias Ruck, Donal McHugh, et al.
Multiple Sclerosis and Related Disorders|June 11, 2022
Immunological consequences of cladribine treatment in multiple sclerosis: A real-world studyLeoni Rolfes, Steffen Pfeuffer, Niklas Huntemann, et al.
Cells|May 13, 2023
Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving CladribineLeoni Rolfes, Steffen Pfeuffer, Jelena Skuljec, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 24, 2021
Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatmentKristina Schönfelder, Helene Schuh, Frederick Pfister, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2023
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With OcrelizumabSteffen Pfeuffer, Leoni Rolfes, Jens Ingwersen, et al.
Pageof 7